- Home
- ARKO vs RLAY Comparison
ARKO vs RLAY Comparison
Compare ARKO & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARKO
- RLAY
- Stock Information
- Founded
- ARKO 1970
- RLAY 2015
- Country
- ARKO United States
- RLAY United States
- Employees
- ARKO N/A
- RLAY N/A
- Industry
- ARKO Oil Refining/Marketing
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ARKO Energy
- RLAY Health Care
- Exchange
- ARKO Nasdaq
- RLAY Nasdaq
- Market Cap
- ARKO 474.7M
- RLAY 490.3M
- IPO Year
- ARKO N/A
- RLAY 2020
- Fundamental
- Price
- ARKO $4.28
- RLAY $3.00
- Analyst Decision
- ARKO Buy
- RLAY Strong Buy
- Analyst Count
- ARKO 4
- RLAY 11
- Target Price
- ARKO $7.19
- RLAY $18.40
- AVG Volume (30 Days)
- ARKO 563.9K
- RLAY 2.2M
- Earning Date
- ARKO 05-08-2025
- RLAY 05-05-2025
- Dividend Yield
- ARKO 2.80%
- RLAY N/A
- EPS Growth
- ARKO N/A
- RLAY N/A
- EPS
- ARKO 0.03
- RLAY N/A
- Revenue
- ARKO $8,488,413,000.00
- RLAY $7,679,000.00
- Revenue This Year
- ARKO N/A
- RLAY N/A
- Revenue Next Year
- ARKO N/A
- RLAY $169.23
- P/E Ratio
- ARKO $164.48
- RLAY N/A
- Revenue Growth
- ARKO N/A
- RLAY N/A
- 52 Week Low
- ARKO $3.51
- RLAY $1.78
- 52 Week High
- ARKO $7.84
- RLAY $10.72
- Technical
- Relative Strength Index (RSI)
- ARKO 41.16
- RLAY 51.78
- Support Level
- ARKO $4.91
- RLAY $2.75
- Resistance Level
- ARKO $5.41
- RLAY $3.10
- Average True Range (ATR)
- ARKO 0.19
- RLAY 0.20
- MACD
- ARKO -0.08
- RLAY 0.01
- Stochastic Oscillator
- ARKO 0.44
- RLAY 54.10
About ARKO ARKO Corp.
ARKO Corp owns and operates convenience stores in the United States. Some of its regional store brands include Stop, Admiral, Apple Market, BreadBox, E-Z Mart, fas mart, Li'l Cricket, and Next Door Store. Its retail store offers hot food service, beverages, cigarettes & other tobacco products, candy, salty snacks, grocery, beer, and general merchandise. ARKO operates in four segments: Retail segment, Wholesale segment, fleet fueling segment, and GPM Petroleum segment. The company derives the majority of its revenue from retail and wholesale distribution of fuel.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).